|
1
|
Ringelhan M, Pfister D, O'Connor T,
Pikarsky E and Heikenwalder M: The immunology of hepatocellular
carcinoma. Nat Immunol. 19:222–232. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Li W, Zeng X, Lee NP, Liu X, Chen S, Guo
B, Yi S, Zhuang X, Chen F, Wang G, et al: HIVID: An efficient
method to detect HBV integration using low coverage sequencing.
Genomics. 102:338–344. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wu G, Ding H and Zeng C: Overview of HBV
whole genome data in public repositories and the Chinese HBV
reference sequences. Prog Nat Sci. 18:13–20. 2008.
|
|
4
|
Sung WK, Zheng H, Li S, Chen R, Liu X, Li
Y, Lee NP, Lee WH, Ariyaratne PN, Tennakoon C, et al: Genome-wide
survey of recurrent HBV integration in hepatocellular carcinoma.
Nat Genet. 44:765–769. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Gehring AJ, Ho ZZ, Tan AT, Aung MO, Lee
KH, Tan KC, Lim SG and Bertoletti A: Profile of tumor
antigen-specific CD8 T cells in patients with hepatitis B
virus-related hepatocellular carcinoma. Gastroenterology.
137:682–690. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lau CC, Sun T, Ching AK, He M, Li JW, Wong
AM, Co NN, Chan AW, Li PS, Lung RW, et al: Viral-human chimeric
transcript predisposes risk to liver cancer development and
progression. Cancer Cell. 25:335–349. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Neuveut C, Wei Y and Buendia MA:
Mechanisms of HBV-related hepatocarcinogenesis. J Hepatol.
52:594–604. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tokino T and Matsubara K: Chromosomal
sites for hepatitis B virus integration in human hepatocellular
carcinoma. J Virol. 65:6761–6764. 1991.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ding D, Lou X, Hua D, Yu W, Li L, Wang J,
Gao F, Zhao N, Ren G, Li L and Lin B: Recurrent targeted genes of
hepatitis B virus in the liver cancer genomes identified by a
next-generation sequencing-based approach. PLoS Genet.
8(e1003065)2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Feitelson MA and Lee J: Hepatitis B virus
integration, fragile sites, and hepatocarcinogenesis. Cancer Lett.
252:157–170. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Taha SE, El-Hady SA, Ahmed TM and Ahmed
IZ: Detection of occult HBV infection by nested PCR assay among
chronic hepatitis C patients with and without hepatocellular
carcinoma. Egypt J Med Hum Genet. 14:353–360. 2013.
|
|
12
|
Li X, Zhang J, Yang Z, Kang J, Jiang S,
Zhang T, Chen T, Li M, Lv Q, Chen X, et al: The function of
targeted host genes determines the oncogenicity of HBV integration
in hepatocellular carcinoma. J Hepatol. 60:975–984. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Guerrieri F, Belloni L, Pediconi N and
Levrero M: Molecular mechanisms of HBV-associated
hepatocarcinogenesis. Semin Liver Dis. 33:147–156. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Rey-Cuille MA, Njouom R, Bekondi C, Seck
A, Gody C, Bata P, Garin B, Maylin S, Chartier L, Simon F and Vray
M: Hepatitis B virus exposure during childhood in Cameroon, Central
African Republic and Senegal after the integration of HBV vaccine
in the expanded program on immunization. Pediatr Infect Dis J.
32:1110–1115. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Bonilla Guerrero R and Roberts LR: The
role of hepatitis B virus integrations in the pathogenesis of human
hepatocellular carcinoma. J Hepatol. 42:760–777. 2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bok J, Kim KJ, Park MH, Cho SH, Lee HJ,
Lee EJ, Park C and Lee JY: Identification and extensive analysis of
inverted-duplicated HBV integration in a human hepatocellular
carcinoma cell line. BMB Rep. 45:365–370. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Arzumanyan A, Reis HM and Feitelson MA:
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular
carcinoma. Nat Rev Cancer. 13:123–135. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Fujimoto A, Totoki Y, Abe T, Boroevich KA,
Hosoda F, Nguyen HH, Aoki M, Hosono N, Kubo M, Miya F, et al:
Whole-genome sequencing of liver cancers identifies etiological
influences on mutation patterns and recurrent mutations in
chromatin regulators. Nat Genet. 44:760–764. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Jiang Z, Jhunjhunwala S, Liu J, Haverty
PM, Kennemer MI, Guan Y, Lee W, Carnevali P, Stinson J, Johnson S,
et al: The effects of hepatitis B virus integration into the
genomes of hepatocellular carcinoma patients. Genome Res.
22:593–601. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Amaddeo G, Cao Q, Ladeiro Y, Imbeaud S,
Nault JC, Jaoui D, Gaston Mathe Y, Laurent C, Laurent A,
Bioulac-Sage P, et al: Integration of tumour and viral genomic
characterisations in HBV-related hepatocellular carcinomas. Gut.
64:820–829. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Murakami Y, Saigo K, Takashima H, Minami
M, Okanoue T, Bréchot C and Paterlini-Bréchot P: Large scaled
analysis of hepatitis B virus (HBV) DNA integration in HBV related
hepatocellular carcinomas. Gut. 54:1162–1168. 2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Saigo K, Yoshida K, Ikeda R, Sakamoto Y,
Murakami Y, Urashima T, Asano T, Kenmochi T and Inoue I:
Integration of hepatitis B virus DNA into the myeloid/lymphoid or
mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in
human hepatocellular carcinoma. Hum Mutat. 29:703–708.
2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li H and Durbin R: Fast and accurate short
read alignment with Burrows-Wheeler transform. Bioinformatics.
25:1754–1760. 2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bauer DC: Variant calling comparison
CASAVA1.8 and GATK. Nat Prec, 2011.
|
|
25
|
Lim L, Tran BM, Vincan E, Locarnini S and
Warner N: HBV-related hepatocellular carcinoma: The role of
integration, viral proteins and miRNA. Future Virol. 7:1237–1249.
2012.
|
|
26
|
Tamori A, Nishiguchi S, Kubo S, Narimatsu
T, Habu D, Takeda T, Hirohashi K and Shiomi S: HBV DNA integration
and HBV-transcript expression in non-B, non-C hepatocellular
carcinoma in Japan. J Med Virol. 71:492–498. 2003.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhao LH, Liu X, Yan HX, Li WY, Zeng X,
Yang Y, Zhao J, Liu SP, Zhuang XH, Lin C, et al: Genomic and
oncogenic preference of HBV integration in hepatocellular
carcinoma. Nat Commun. 7(12992)2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhang Z: Abstract LB-400: The effects of
hepatitis B virus integration into the genomes of hepatocellular
carcinoma patients. Cancer Res. 72 (Suppl 8):LB–400.
2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bréchot C, Gozuacik D, Murakami Y and
Paterlini-Bréchot P: Molecular bases for the development of
hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).
Semin Cancer Biol. 10:211–231. 2000.PubMed/NCBI View Article : Google Scholar
|
